There was a nominally significant higher frequency of mutations in cases compared with controls for POLK , PALB2 and SLX4 and a lower frequency of mutations in cases compared with controls for FBXO10 ( table 1 ).
← all excerpts
Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer.
1
—
—